ADOCIA Company Contacts

ADOCIA

http://www.adocia.com
"Innovative medicine for everyone, everywhere"​ Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease... Read More
Contacts

Country

France

City

LYON

Headquarters

LYON, FR

Profile

Founded

2005

Industry

Biotechnology Research

Size

51 - 200

Specialties

Therapeutic proteins, BioChaperone®, Next-generation injectables for diabetes treatment, Ultra-rapid Insulin, Multi-agents injectable combination, Diabetes, Metabolic diseases, Amylin, Innovative protein formulations, Glucagon

Funding

Total Rounds

3

Last Round

Mon Oct 25 2021

Last Round Series

Post IPO debt

Last Round Raised

$ 6,957,901